Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$702.2K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
3 of 8 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 33 business days late.
The 13 most recent Form 4 transactions.
| — |
| Filing ↗ |
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Jun 18 | RCKT | Rocket Pharmaceuticals,… | AGRANT | 22,862 | — | — | +51.7% | Open the original filing on SEC.gov |
| May 29 | A | Agilent Technologies, INC. | SSELL | 1,600 | $135.42 | $216.7K | -22.4% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS◆ | 24,135 | — | — | — | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | DTOISS | 14,312 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 14 | APLS | Apellis Pharmaceuticals,… | UTENDR | 14,312 | — | — | -100.0% | Open the original filing on SEC.gov |
| Mar 19 | A | Agilent Technologies, INC. | AGRANT | 2,158 | $111.75 | $241.2K | +43.3% | Open the original filing on SEC.gov |
| Feb 27 | APLS | Apellis Pharmaceuticals,… | AGRANT◆ | 24,135 | $20.96 | $505.9K | — | Open the original filing on SEC.gov |
| Feb 27 | APLS | Apellis Pharmaceuticals,… | AGRANT | 14,312 | — | — | — | Open the original filing on SEC.gov |
| Dec 1, 2025 | A | Agilent Technologies, INC. | SSELL | 2,600 | $149.81 | $389.5K | -34.3% | Open the original filing on SEC.gov |
| Jun 18, 2025 | RCKT | Rocket Pharmaceuticals,… | AGRANT | 30,000 | — | — | +211.0% | Open the original filing on SEC.gov |
| Mar 5, 2025 | RCKT | Rocket Pharmaceuticals,… | JOTHER | 14,220 | — | — | — | Open the original filing on SEC.gov |